| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Null Mice
Department of Molecular and Cellular Biology (T.M.P., F.J.D.,
M.M.M., S.Y.T., B.W.O.) Department of Pathology (M.M.M.), and
Department of Molecular and Human Genetics (M.M.M.) Baylor College
of Medicine Houston, Texas 77030
Schering-Plough Corp. Research Institute
(Y.W.) Kenilworth, New Jersey
07033
Exogenous regulation of protein expression creates
the potential to examine the consequences of homeostatic Dysregulation
in many physiological systems and, when used in transgenic mice,
provides the capability of restoring a gene product to its knockout
background without antigenicity issues. In this study, we used a
mifeprisone-inducible system (the GeneSwitch system) to regulate the
expression of inhibin A from the liver of mice. Inhibin is a
heterodimeric protein (
/ß) wherein one of its subunits (ß) is
capable of homodimerizing to form its physiological antagonist, activin
(ß/ß). Inhibin is also expressed in two forms, A and B, as
determined by the subtype of ß-subunit that dimerizes with the
-subunit (
/ßA or
/ßB). To utilize the GeneSwitch system,
transgenic transactivator mice with liver-specific expression of a
mifepristone-activated chimeric nuclear receptor (GLVP) were
crossed with transgenic target mice containing a GVLP-responsive
promoter upstream of poliovirus IRES (internal ribosome entry
site)-linked sequences coding for the
- and ß-subunits of inhibin
A. This intercross produced "bigenic" mice capable of regulable
expression of inhibin A from the liver. Overexpression of inhibin A in
wild-type mice produced a phenotype wherein males had decreased testis
size and females had a block in folliculogenesis at the early antral
stage, findings similar to activin type IIA receptor (ActRIIA) null
mice. These phenotypes were most likely due to suppressed serum FSH,
confirming that the liver-derived inhibin A was secreted into the serum
to down-regulate pituitary FSH levels. Furthermore, the generation of
bigenic mice in the inhibin
null background allowed for the
induction of inhibin A in inhibin
null male mice with subsequent
rescue of these mice from their gonadal tumor-induced lethal phenotype.
This work demonstrates the in vivo production of a
heterodimeric hormone from a single inducible promoter to study its
therapeutic and physiological effects. In addition, these studies are
the first example of an inducible system being used to prevent a lethal
knockout phenotype in an animal model.
This article has been cited by other articles:
![]() |
M. R. Sowers, A. D. Eyvazzadeh, D. McConnell, M. Yosef, M. L. Jannausch, D. Zhang, S. Harlow, and J. F. Randolph Jr. Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3478 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Bilezikjian, A. L Blount, C. J Donaldson, and W. W Vale Pituitary actions of ligands of the TGF-{beta} family: activins and inhibins. Reproduction, August 1, 2006; 132(2): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Itman, S. Mendis, B. Barakat, and K. L. Loveland All in the family: TGF-{beta} family action in testis development. Reproduction, August 1, 2006; 132(2): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Z. Altuntas, J. M. Johnson, and V. K. Tuohy Autoimmune Targeted Disruption of the Pituitary-Ovarian Axis Causes Premature Ovarian Failure J. Immunol., August 1, 2006; 177(3): 1988 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Burns, J. E. Agno, P. Sicinski, and M. M. Matzuk Cyclin D2 and p27 Are Tissue-Specific Regulators of Tumorigenesis in Inhibin {alpha} Knockout Mice Mol. Endocrinol., October 1, 2003; 17(10): 2053 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bockamp, M. Maringer, C. Spangenberg, S. Fees, S. Fraser, L. Eshkind, F. Oesch, and B. Zabel Of mice and models: improved animal models for biomedical research Physiol Genomics, December 3, 2002; 11(3): 115 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. van der Weyden, D. J. Adams, and A. Bradley Tools for targeted manipulation of the mouse genome Physiol Genomics, December 3, 2002; 11(3): 133 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chang, C. W. Brown, and M. M. Matzuk Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily Endocr. Rev., December 1, 2002; 23(6): 787 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Burns and M. M. Matzuk Minireview: Genetic Models for the Study of Gonadotropin Actions Endocrinology, August 1, 2002; 143(8): 2823 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Mills Changing colors in mice: an inducible system that delivers Genes & Dev., June 15, 2001; 15(12): 1461 - 1467. [Full Text] [PDF] |
||||
![]() |
S. C. Cipriano, L. Chen, K. H. Burns, A. Koff, and M. M. Matzuk Inhibin and p27 Interact to Regulate Gonadal Tumorigenesis Mol. Endocrinol., June 1, 2001; 15(6): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Huhtaniemi and A. Bartke Perspective: Male Reproduction Endocrinology, June 1, 2001; 142(6): 2178 - 2183. [Full Text] [PDF] |
||||
![]() |
F. Zindy, W. den Besten, B. Chen, J. E. Rehg, E. Latres, M. Barbacid, J. W. Pollard, C. J. Sherr, P. E. Cohen, and M. F. Roussel Control of Spermatogenesis in Mice by the Cyclin D-Dependent Kinase Inhibitors p18Ink4c and p19Ink4d Mol. Cell. Biol., May 1, 2001; 21(9): 3244 - 3255. [Abstract] [Full Text] |
||||
![]() |
B. Zhao, S. S. Chua, M. M. Burcin, S. D. Reynolds, B. R. Stripp, R. A. Edwards, M. J. Finegold, S. Y. Tsai, and F. J. DeMayo Phenotypic consequences of lung-specific inducible expression of FGF-3 PNAS, April 25, 2001; (2001) 101116598. [Abstract] [Full Text] |
||||
![]() |
B. Zhao, S. S. Chua, M. M. Burcin, S. D. Reynolds, B. R. Stripp, R. A. Edwards, M. J. Finegold, S. Y. Tsai, and F. J. DeMayo Phenotypic consequences of lung-specific inducible expression of FGF-3 PNAS, May 8, 2001; 98(10): 5898 - 5903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |